David P. Kelsen

22.7k citations

292 papers · 14.6k indexed · 1 hit paper · h-index 72

Impact in

Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Gastroenterology top 0.2%

Papers in

Oncology 185
- Pancreatic and Hepatic Oncology Research 63
- Colorectal Cancer Treatments and Studies 51
- Cancer Treatment and Pharmacology 29
- Lung Cancer Research Studies 26
Pulmonary and Respiratory Medicine 149
- Gastric Cancer Management and Outcomes 101
- Lung Cancer Treatments and Mutations 45

Co-authors: Leonard B. Saltz Manish A. Shah Gary K. Schwartz Eileen M. O’Reilly David H. Ilson David S. Klimstra Laura H. Tang Nancy E. Kemeny
Journals: Journal of Clinical Oncology (88 papers)Cancer (36 papers)Clinical Cancer Research (8 papers)Annals of Oncology (8 papers)Investigational New Drugs (8 papers)
Partner nations: United States Israel Canada

In The Last Decade

David P. Kelsen

288 papers receiving 14.1k citations

Hit Papers

align trajectories log scale

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry 2005 · 848 citations

Peers

Countries citing papers authored by David P. Kelsen

Since Specialization

Citations

This map shows the geographic impact of David P. Kelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Kelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Kelsen more than expected).

Fields of papers citing papers by David P. Kelsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Kelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Kelsen. The network helps show where David P. Kelsen may publish in the future.

Co-authors

The 25 scholars most cited alongside David P. Kelsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David P. Kelsen Line = papers co-authored together David P. Kelsen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1504MO Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum Annals of Oncology ·Won Park, Charles Connor, J. Chou, Carly Schwartz, M. Larsen, Anna M. Varghese, Kenneth H. Yu, Fiyinfolu Balogun, J. Yang, Seth S. Katz, David P. Kelsen, Shigeaki Umeda, Chaitanya Bandlamudi, Nadeem Riaz, Michael F. Berger, Vinod P. Balachandran, Dan Peer, M. Capanu, Christine A. Iacobuzio–Donahue, Eileen M. O’Reilly	2024	2
2	Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response Cell Reports ·Chen Lior, Debra Barki, Coral Halperin, Christine A. Iacobuzio–Donahue, David P. Kelsen, Ruth Scherz‐Shouval	2024	16
3	Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study JMIR Public Health and Surveillance ·Irit Ben‐Aharon, Ran S. Rotem, Cheli Melzer Cohen, Gilad Twig, Andrea Cercek, Elizabeth Half, Tal Goshen‐Lago, Gabriel Chodik, David P. Kelsen	2023	4
4	Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer Cancer ·Kenneth H. Yu, Jennifer Park, Avni Mittal, Ghassan K. Abou‐Alfa, Imane El Dika, Andrew S. Epstein, David H. Ilson, David P. Kelsen, Geoffrey Y. Ku, Jia Li, Wungki Park, Anna M. Varghese, Joanne F. Chou, Marinela Capanu, Brandon Cooper, Andrew A. Bartlett, Devan McCarthy, Vineet Sangar, Brian P. McCarthy, Eileen M. O’Reilly	2022	7
5	Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice Clinical Cancer Research ·Wungki Park, Catherine O’Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda, Marsha Reyngold, Anna M. Varghese, Fergus Keane, Fiyinfolu Balogun, Kenneth H. Yu, David P. Kelsen, Christopher H. Crane, Marinela Capanu, Christine A. Iacobuzio–Donahue, Eileen M. O’Reilly	2022	13
6	Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis Clinical Colorectal Cancer ·Rona Yaeger, Viktoriya Paroder, ‬David D. B. Bates, Marinela Capanu, Joanne Chou, Laura Tang, Walid K. Chatila, Nikolaus Schultz, Jonathan Hersch, David P. Kelsen	2020	8
7	Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma Cancer ·Caitlin A. McIntyre, Sharon Lawrence, Allison L. Richards, Joanne F. Chou, Winston Wong, Marinela Capanu, Michael F. Berger, Mark T.A. Donoghue, Kenneth H. Yu, Anna M. Varghese, David P. Kelsen, Wungki Park, Vinod P. Balachandran, T. Peter Kingham, Michael I. D’Angelica, Jeffrey A. Drebin, William R. Jarnagin, Christine A. Iacobuzio–Donahue, Peter J. Allen, Eileen M. O’Reilly	2020	49
8	Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer Nature Communications ·Oshrat Levi-Galibov, Hagar Lavon, Rina Wassermann-Dozorets, Meirav Pevsner‐Fischer, Shimrit Mayer, Esther Wershof, Yaniv Stein, Lauren E. Brown, Wenhan Zhang, Gil Friedman, Reinat Nevo, Ofra Golani, Lior H. Katz, Rona Yaeger, Ido Laish, John A. Porco, Erik Sahai, Dror S. Shouval, David P. Kelsen, Ruth Scherz‐Shouval	2020	67
9	Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer Clinical Cancer Research ·Megan Greally, Joanne F. Chou, Walid K. Chatila, Matthew Margolis, Marinela Capanu, Jaclyn F. Hechtman, Yaelle Tuvy, Ritika Kundra, Foysal Daian, Marc Ladanyi, David P. Kelsen, David H. Ilson, Michael F. Berger, Laura H. Tang, David B. Solit, Luis A. Díaz, Nikolaus Schultz, Yelena Y. Janjigian, Geoffrey Y. Ku	2019	75
10	Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer Clinical Cancer Research ·Elizabeth Won, Azfar Basunia, Walid K. Chatila, Jaclyn F. Hechtman, Joanne F. Chou, Geoffrey Y. Ku, Sree B. Chalasani, Michelle S. Boyar, Zoe Goldberg, Avni M. Desai, Yaelle Tuvy, Michael F. Berger, Laura Tang, David P. Kelsen, Mark Schattner, David H. Ilson, Marinela Capanu, David B. Solit, Nikolaus Schultz, Yelena Y. Janjigian	2019	14
11	Abstract No. 617 Nonthermal ablation of pancreatic cancer in a pig model, using vascular-targeted photodynamic therapy (VTP) Journal of Vascular and Interventional Radiology ·Hooman Yarmohammadi, Fuad Nurili, Masashi Fujimori, Sébastien Monette, David P. Kelsen, Jonathan Coleman, Eileen M. O’Reilly, Lawrence B. Schook, Stephen B. Solomon, Avigdor Scherz, Govindarajan Srimathveeravalli, F. Boas	2019	1
12	Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials European Journal of Cancer ·Ulrich Ronellenfitsch, Katrin Jensen, Svenja Seide, Meinhard Kieser, Matthias Schwarzbach, Tracy Slanger, Bryan Burmeister, David P. Kelsen, Donna Niedzwiecki, Guillaume Piessen, Christoph Schuhmacher, Susan G. Urba, Cornelis J.�H. van de Velde, Marc Ychou, Ralf‐Dieter Hofheinz, Sylvie Lorenzen	2019	12
13	A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma Journal of Hepatology ·Ghassan K. Abou‐Alfa, Marinela Capanu, Eileen M. O’Reilly, Jennifer Ma, Joanne F. Chou, Bolorsukh Gansukh, Jinru Shia, Marcia F. Kalin, Seth S. Katz, Leslie W. Abad, Diane Reidy‐Lagunes, David P. Kelsen, Helen X. Chen, Leonard B. Saltz	2013	83
14	Molecular Classification of Gastric Cancer: A New Paradigm Clinical Cancer Research ·Manish A. Shah, Raya Khanin, Laura H. Tang, Yelena Y. Janjigian, David S. Klimstra, Hans Gerdes, David P. Kelsen	2011	235
15	A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors Clinical Cancer Research ·Archie Tse, David S. Klimstra, Mithat Gönen, Manish Shah, Tahir Sheikh, Rachel Sikorski, Richard D. Carvajal, Janet Mui, Caroll Tipian, Eileen M. O’Reilly, Ki Wook Chung, Robert G. Maki, Robert A. Lefkowitz, Karen T. Brown, Katia Manova‐Todorova, Nian Wu, Merrill J. Egorin, David P. Kelsen, Gary K. Schwartz	2008	49
16	Principles and practice of gastrointestinal oncology Lippincott Williams & Wilkins eBooks ·David P. Kelsen	2008	25
17	UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. PubMed ·Chung-Tsen Hsueh, David P. Kelsen, Gary K. Schwartz	1998	68
18	Management of esophageal cancer. PubMed ·David H. Ilson, David P. Kelsen	1996	11
19	THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER Chest Surgery Clinics of North America ·David P. Kelsen	1994	1
20	Phase II trials of methylglyoxal bis (guanylhydrazone) (MGBG) in 3 solid tumors Proceedings of the American Association for Cancer Research ·Robert Chapman, David P. Kelsen, Richard J. Gralla	1981	2

About David P. Kelsen

David P. Kelsen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Cancer Research and Surgery, having authored 292 papers that have together received 14.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (101 papers), Pancreatic and Hepatic Oncology Research (63 papers), Colorectal Cancer Treatments and Studies (51 papers), Lung Cancer Treatments and Mutations (45 papers), Esophageal Cancer Research and Treatment (37 papers), Cancer Genomics and Diagnostics (36 papers), Cancer Treatment and Pharmacology (29 papers) and Lung Cancer Research Studies (26 papers). The work is most often cited by research in Oncology (8.9k citations), Gastroenterology (1.1k citations), Pulmonary and Respiratory Medicine (6.3k citations), Cancer Research (1.9k citations) and Surgery (4.2k citations). David P. Kelsen has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Leonard B. Saltz, Manish A. Shah, Gary K. Schwartz, Eileen M. O’Reilly, David H. Ilson, David S. Klimstra, Laura H. Tang, Nancy E. Kemeny, Marinela Capanu and Ephraim S. Casper. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, Annals of Oncology and Investigational New Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact